Improving Verification & Validation in the Medical Device Domain by Sivakumar, M S et al.
Improving Verification & Validation in the Medical Device Domain 
M.S. Sivakumar, Valentine Casey, Fergal McCaffery, Gerry Coleman 
Regulated Software Research Group, 
Dundalk Institute of Technology & Lero, Ireland 
{Sivakumar.Madhavakuruppu, Val.Casey, Fergal.McCaffery, Gerry. Coleman}@dkit.ie 
 
Abstract    
The benefits of effective verification and validation activities in the medical device domain 
include increased usability and reliability, decreased failure rate and recalls and reduced 
risks to patients and users. Though there is guidance on verification and validation in 
multiple standards in the medical device domain, these are difficult for the manufacturer to 
implement, as there is no consolidated information on how they can be successfully 
achieved. The paper highlights three major areas for improvement in the medical device 
software development domain. This research is based on an analysis of available literature 
in the field of verification and validation in generic software development, safety-critical and 
medical device software domains. Additionally, we also performed a review of the standards 
and process improvement models available in these domains.    
Keywords: Medical device standards, Medical device software verification and validation, 
V&V, Medical device software process assessment and improvement, Medi SPICE 
 
1.  Introduction 
Verification and Validation (V&V) are amongst the most important activities in the software 
development lifecycle and consume up to 50% of project development time [1], [2] and up to 
50% of the total cost [3]. The concepts of V&V emerged in the late 1960s and 1970s as the 
use of software in military and nuclear power systems increased.  Initially, individual projects 
began to develop their own standards to address the need for V&V. Then government and 
industry began to develop V&V standards so they would have a specified approach for 
contract procurement and for monitoring the technical performance of V&V efforts. V&V 
standards and guidelines serve large, heterogeneous communities and are applicable to 
many types of software. These  include the following:  
1. The US Air Force‘s AFSCIAFLC 600-5, Software Independent Verification and 
Validation [4] 
2. The American Nuclear Society‘s ANS 10.4, Guidelines for the Verification and 
Validation of Scientific and Engineering Computer Programs for the Nuclear Industry [4] 
3. The NASA Jet Propulsion Laboratory‘s JPL D-576, Independent Verification and 
Validation of Computer Software: Methodology [4] 
4. The Food and Drug Administration (FDA) Center for Devices and Radiological Health 
(2002) General Principles of Software Validation (GPSV) [5] for medical devices 
 While both V&V play a key role in software development, there is a level of ambiguity in the 
use of these terms.  This is evident in the literature as the following definitions demonstrate: 
• Berling, and Thelin argue that verification aims at checking that the system as a 
whole works according to its specifications and validation aims at checking that the system 
behaves according to the customers' intentions [6] 
• Arthur, Groner, Hayhurst, and Holloway cite in one of their papers that verification 
refers to the process of examining each development phase to ensure that the output of a 
particular phase satisfies all the pertinent requirements of the previous phase, is internally 
acceptable, and can support the development effort in the next phase. Validation, on the 
other hand, is an activity primarily concerned with software testing. During validation you 
execute the system and compare the test results to the requirements [7] 
• Wallace and Fujii state that verification involves evaluating software during each 
lifecycle phase to ensure that it meets the requirements set forth in the previous phase and 
validation involves testing software or its specification at the end of the development effort to 
ensure that it meets its requirements (that it does what it is supposed to). They go on to say 
that while ‗verification‖ and ―validation‖ have separate definitions, you can derive the 
maximum benefit by using them synergistically and treating ―V&V‖ as an integrated 
definition. [4] 
As these definitions highlight, the terms verification and validation are often used 
interchangeably whereas in the strict sense the objectives of these two processes are 
different.  While they may both employ the same techniques or environment while 
performing these processes. 
The main activities of verification and validation are reviews and testing. Software testing 
cannot be conducted until the software product is built. Since faults need to be found early, 
software inspections are conducted before the product has been implemented [6]. The 
difference between validation and verification can be explained by looking at the purpose of 
the tests performed. The use of prototypes to test if requirements can be addressed is an 
example of a verification practice. The evaluation of a prototype by the users to test if the 
product fulfills their needs is an example of a validation practice. In other words, we can say 
that the verification should ask ―Are you meeting the specified requirements?‖ and ―Are you 
building the product right?‖ In the same way we can say that the validation should ask ―Are 
you meeting the operational need?‖ ―Does this product meet its intended use in the intended 
environment?‖ and ―Are you building the right product?‖ [8]. ANSI/IEEE Std 1012 [9], 
Standard for Software Verification and Validation Plans provides a set of minimum V&V 
tasks for each of the lifecycle phases in a software project. 
 
2.  Research Approach  
We performed our research to undertake this study, the following phases: 
• The V&V processes were reviewed in detail to understand how they were addressed 
in the context of generic software development. The review included relevant literature, 
standards and process improvement models such as Capability Maturity Model® Integrated 
(CMMI®) [10], and ISO/IEC 15504-5 [11].   
• Research was undertaken in the domain of safety-critical software development and 
V&V in this context. This included conducting a  review of how the V&V processes were 
addressed by safety-critical software development standards such as DO-178B [12] and 
Automotive SPICE [13] 
• Medical device software V&V was extensively researched. To this end a detailed 
analysis of the medical device standards was undertaken which included ISO/IEC 13485 
[14], ISO/IEC 62304 [15], ISO/IEC 14971 [16] and the Food and Drug Administration (FDA) 
Guidelines for Software Validation (FDA GPSV).    
• From the comparative analysis performed, we arrived at a set of findings which 
suggest areas for improving V&V practices in the medical device software domain 
 
 
3.  Verification and Validation in Generic Software Development 
Two important reference models which are widely used in the context of software process 
improvement are the Capability Maturity Model® Integrated (CMMI®) and ISO/IEC 15504-5. 
They address the software verification and validation processes in the following ways: 
CMMI® in line with ANSI/IEEE Std 1012-1986   recommends a lifecycle view for verification 
and validation activities. It defines verification as ―Confirmation that work products properly 
reflect the requirements specified for them‖. In other words, verification ensures that ‗you 
built it right‘ and validation as ―Confirmation that the product, as provided (or as it will be 
provided), will fulfill its intended use‖. Therefore, validation ensures that ‗you built the right 
product‘. The verification and validation processes are part of the engineering processes 
category and both are level 3 process areas in the staged model.  
The verification process area in CMMI® is used by many of the other process areas 
irrespective of the category they fall into. These processes include Project Planning, 
Measurement & Analysis and other support process areas.  The verification process is used 
to verify the work products created from the performance of these processes. Verification is 
also used extensively in the context of the engineering process areas which includes 
Requirements Management, Requirements Development, Technical Solution and Product 
Integration. The model also provides guidance in terms of examples of methods like peer 
reviews, statement coverage testing, and branch coverage testing that could be used in this 
context. 
The validation process area incrementally validates products against the customer‘s needs. 
Validation may be performed in the operational environment or simulated operational 
environment. Coordination with the customer on the validation requirements is an important 
element of this process area. The scope of the validation process area includes validation of 
products, product components, selected intermediate work products, and processes. These 
validated elements may often require re-verification and revalidation.  
Validation activities can be applied to all aspects of the product in any of its intended 
environments, such as operation, training, manufacturing, maintenance, and support 
services. Like the verification process area, validation is also performed during the course of 
the product development as it moves from each phase of the lifecycle. For example in the 
requirements phase, the model suggests analysis, simulations, prototyping and 
demonstrations as possible techniques for validation. Both validation and verification 
activities often run concurrently and may use portions of the same environment.  
Similar to CMMI®, verification and validation have two distinct processes in ISO/IEC 15504-
5. Verification and validation are under the supporting life cycle process category and the 
source for both these processes are   ISO/IEC 12207 AMD1 [17].  
In ISO/IEC 15504-5, the purpose of the verification process is to confirm that each software 
work product and/or service of a process or project properly reflects the specified 
requirements. The tasks pertaining to verification include: development of a verification 
strategy, development of criteria for verification, performing the activity of verification, 
determination of actions based on verification results and making the results available to the 
stakeholders.  
As per ISO/IEC 15504-5, the purpose of the validation process is to confirm that the 
requirements for a specific intended use of the software work product are fulfilled. Validation 
aims to confirm by examination and provision of objective evidence that software or system 
specifications conform to user needs and intended uses, and the particular requirements 
implemented by the software product can be consistently fulfilled.   The tasks pertaining to 
validation include: the development of a validation strategy and criteria for validation, 
performing the validation activities and the identification of problems, providing the validation 
data and making the results available to customers and other stakeholders. 
The state of adoption of formal process management for V&V varies across organizations 
depending on the size and nature of business/products being developed. A study on the 
state of practice of V&V in industry [18] reveals the following: the process is more 
emphasized in large organizations while smaller organizations have identified 
inconsistencies in the documentation standard, but did not consider non-adherence to 
processes as being too harmful.  
Though CMMI®, pays attention to V&V, it is still rather modest in its focus on these areas 
compared to other elements of the development processes [19]. As stated, industry-wide 
experiences indicate that validation and verification activities typically consume about 30-
50% of development budgets [20]. In May of 2007, a working group was formed by ISO/IEC 
to produce a new software testing standard (the ISO/IEC 29119). The development of the 
standard is expected to be completed by May - October 2012 [21].  
Our analysis points to the fact that the general software development standards and process 
improvement models need to be adapted to meet the specific requirements of medical 
device software development, which is highly regulated and safety-critical in nature. 
 
4.  Verification and Validation in Safety-critical Domains 
In order to review the  V&V processes for software development in the safety-critical medical 
device domain, a relevant approach was to determine how verification and validation is 
addressed in the safety-critical software development domains of aerospace, avionics, 
space, nuclear and automotive. As with medical devices, software in these areas is a critical 
element of complex, potentially dangerous problems and failures in these products can 
result in loss of life, significant environmental damage, and major financial loss [22]. 
 In the development of safety-critical systems, the speed of technology and rising demand 
for improved productivity has created a host of new challenges. These include issues such 
as, known safety techniques are not applied, ability to demonstrate (certify) that safety 
requirements have been met is inadequate, and automated code generators, automated 
testing tools etc. which are used to improve productivity may have associated problems 
which may be poorly understood [23]. In addition, designed products are required to meet a 
very high-level of reliability, security, and performance in safety-critical areas as many of 
them could pose serious threat to users/consumers or the general public. Therefore, 
ensuring that such systems meet their predefined requirements and that they perform as 
expected is a challenging issue [24]. 
It has been found that there is a relationship between the increasing occurrence of system 
accidents and the increasing usage of software [25]. Within the safety-critical software 
arena, different standards/certifications are available for different industries. These include 
the DO-178B for Aerospace, and Automotive SPICE and ISO 26262 [26] in the Automotive 
industry.  IEC 60880 [27] describes the European standards for certification of nuclear power 
generating software.  IEC 61508 [28] describes a general-purpose hierarchy of safety-critical 
development methodologies that has been applied to a variety of domains ranging from 
medical instrumentation to electronic switching of passenger railways. Though these 
standards address verification and validation in sufficient detail, their role is not to address 
process improvement. In addition, there are some authors [29] who consider that V&V 
assessment in CMMI® is not adequate when dealing with safety-critical software, and they 
proposed a new framework for V&V assessment, focused on   safety-criticality. This 
framework is defined using safety standards together with the CMMI® V&V process areas 
and the ISO 9001 standard [30]. 
Some of the key differences between safety-critical standards and generic-software 
development standards/models highlighted in our research were as follows:  
a. Risk Management 
Risk Management  involves the identification and management of risk. Risk assessment is a 
function of impact and the probability of occurrence. A risk based approach to safety allows 
the hazards associated with a system to be identified and prioritized. The risk assessment 
involves calculation of level of risk associated with a hazard. 
b. Integrity levels 
Several standards use the concept of integrity levels to define the application of effort and 
rigour appropriate to the criticality of a component. In DO-178B, there are software levels 
starting from A to E (A being highest and E being lowest). ISO 26262 assigns the value of 
the ASILs (Automotive Safety Integrity Levels) from D (most critical), to A (least critical), 
based on IEC 61508   
c. Stress on Independence 
Independence in verification and validation is important because the developer of the 
software product may have a biased opinion about their own product and therefore possibly 
miss performing certain verification/validation activities.   
d. Qualification of tools [31] 
Section 12.2 of DO-178B, specifies that the objective qualification of tools used in 
development (which includes verification and validation tools) is to ensure that the tool 
provides confidence at least equivalent to that of the processes eliminated, reduced, or 
automated. 
We examined these factors for the purpose of identifying a set of improvements for the 
medical device software domain.  
 
5.  Improvement in V&V in the Medical Device Software Domain  
The applicable standards in the problem domain of medical device software development 
are ISO 13485, ISO/IEC 62304, ISO/IEC 14971 and  FDA GPSV. We analysed how the 
areas of verification and validation are addressed by these standards in detail as well as in 
the relevant literature. We then compared our findings to standards and process 
improvement models in general software development and other safety-critical domains, 
which included the aerospace and automotive industry. As a result of this analysis we 
identified three key areas which need to be addressed for improvement in the context of 
verification and validation for medical device software development. These are as follows: 
 
5.1 Having Distinct Processes for Verification and Validation 
ISO 13485 represents the requirements for a comprehensive management system for the 
design and manufacture of medical devices. As per ISO 13485, verification is performed to 
ensure that the design and development outputs have met the design and development 
input requirements. Design and development validation is carried out to ensure that the 
resulting product is capable of meeting the requirements for the specified application as 
defined in relation to its intended use. Validation should be completed prior to the delivery or 
implementation of the product. However, the level of detail available for verification and 
validation in ISO 13485 is not sufficient for an effective implementation of these processes in 
the context of medical device software.   
 To address this, manufacturers rely on ISO/IEC 62304, which provides a framework of life 
cycle processes with activities and tasks necessary for the development and maintenance of 
medical device software. In this context the standard defines the software development 
lifecycle as a conceptual structure spanning the life of the software from the definition of its 
requirements to its release and maintenance.  In ISO/IEC 62304, verification is confirmed 
through the provision of objective evidence that the specified requirements have been 
fulfilled. ISO/IEC 62304 identifies the milestones at which the completeness of specified 
deliverables are verified thus stressing the importance of verification. ISO/IEC 62304 
expects that verification will be covered as part of each lifecycle activity from requirements to 
software release. Though the standard does address software verification, it considers 
validation to be a system level process and is therefore outside its scope even when the 
system is entirely software.  
 The FDA‘s GPSV outlines the general verification and validation principles that the FDA 
considers applicable to the validation of medical device software or the validation of software 
used to design, develop, or manufacture medical devices. As per the FDA GPSV, software 
verification provides objective evidence that the design outputs of a particular phase of the 
software development lifecycle meets all of the specified requirements for that phase. 
Software verification looks for consistency, completeness, and correctness of the software 
and its supporting documentation, as it is being developed, and provides support for a 
subsequent conclusion that software is validated. Even though validation is defined in 
Section 3.1.2 of the FDA GPSV, it is not covered thereafter in the guidelines.   
 ISO 14971 is a standard for performing risk based activities in the medical device domain. 
ISO 14971 states that verification is ―confirmation, through the provision of objective 
evidence, that specified requirements have been fulfilled‖. Two distinct types of verifications 
are required by the standard: (1) Verification to confirm that the risk control measure has 
been implemented in the final design. (2) Verification to ensure that the measure as 
implemented actually reduces the risk. In some instances, a validation study can be used for 
verifying the effectiveness of the risk control measure.   
 
5.1.1 Improving Verification and Validation through separation of these two processes 
Since ISO 14971 does not provide guidance on the verification and validation activities that 
should be performed manufacturers rely on ISO 13485 and ISO/IEC 62304 for 
implementation of verification and validation.  As a result it can be difficult for the software 
manufacturers to meet the requirements of the risk management standard effectively. 
 As the processes of V&V are critical to software development in the medical devices 
domain, there needs to be a mechanism by which manufacturers could assess where they 
stand with respect to these processes and identify possible improvement opportunities. 
Manufacturers would also require a benchmark in terms of verification and validation 
processes to evaluate a potential vendor‘s capability in these processes. Hence it becomes 
necessary that a set of distinct processes be defined for verification and validation. Further, 
manufacturers would greatly benefit from the definition of a set of practices for verification 
and validation which relate to each of the engineering processes.  
 
5.2 Independence in Verification and Validation 
The IEEE Standards for Software Verification and Validation state that classical Independent 
Verification and Validation (IV&V) is generally required for the development of software 
systems deemed ―critical‖ in nature, i.e., those which can result in loss of life, mission or 
significant social or financial loss [32]. The results of a study [7] highlight the difference in 
fault detection capabilities between two methods – non-independent V&V and Independent 
V&V (IV&V).  The results indicate that IV&V provided a significant value-added component to 
the software development process. Independence is an important factor addressed by DO-
178B and gives specific guidance on the subject.  
ISO/IEC15504-5 and Automotive SPICE state that ―degrees of independence‖ is something 
each project has to plan as part of its verification and validation strategy. The FDA GPSV 
addresses independence in Section 4.9, but leaves it to the discretion of device 
manufacturers on how this is to be achieved. ISO/IEC 62304 does not mandate 
independence.  Independence is addressed in ISO 13485 in section 5.5.1 - Responsibility 
and Authority, where it states: ―Top management shall establish the interrelation of all 
personnel who manage, perform and verify work affecting quality, and shall ensure the 
independence and authority necessary to perform these tasks‖.  
 
5.2.1 Improving Verification and Validation by making them independent of development 
Section F.3 of ISO 14971 states that the risk management plan should identify the personnel 
with responsibility for the execution of specific risk management activities, for example, 
reviewer(s), expert(s), independent verification specialist(s), individual(s) with approval 
authority (see 3.2). This assignment can be included in a resource allocation matrix defined 
for the design project. From the statement, we can assume that the standard recognizes the 
need for independent verification specialist(s).  Since ISO 14971 relies on other standards 
like the ISO 13485 for implementation of verification and validation, the manufacturers may 
have to look for additional guidance for implementation. As we have seen in the case of ISO 
13485 and the FDA GPSV, though independence in verification and validation is addressed 
implicitly, there needs to be further guidance on which phases/engineering activities would 
require independence in verification and validation.  
 
5.3 Qualification of Tools  
The tools to be used in software development should be evaluated to ensure they 
adequately address the requirements for which they are being procured. In a safety-critical 
domain like Aerospace, the software verification process objectives for software 
development tools are described in the DO-178B standard. Tools are classified into software 
development tools and software verification tools. The qualification criteria for software 
verification tools are specifically addressed in the standard. ISO 13485 and ISO/IEC 62304 
do not address this requirement, which is essential for safety-critical software development.  
 In terms of qualification of tools in software development and verification and validation 
activities, the FDA GPSV states that most of the automated equipment and systems used by 
device manufacturers are supplied by third party vendors and are purchased Off-The-Shelf 
(OTS). It gives guidance on validation of OTS software and automated equipment in section 
6.3. The standard states that the vendor‘s life cycle documentation, such as testing protocols 
and results, source code, design specification, and requirements specification can be useful 
in establishing that the software has been validated. The standard however states that 
documentation may not be available from the product vendors as they might not be willing to 
share proprietary information. The standard suggests a number of practices which could be 
adopted by the device manufacturer given the lack of available documentation from the 
vendors.  
 
5.3.1 Improving Verification and Validation by using appropriate tools 
Given what the standards propose, qualification of tools in the software development and 
V&V context needs to be addressed consistently in the medical device domain. 
Due to delivery schedule pressures and shortfall in properly trained software engineers, the 
development of medical device software and systems has not kept pace with software 
assurance techniques practiced in other safety-critical domains such as avionics [33]. Apart 
from this, the lack of standard architectures for medical device software and the lack of 
integrated standard principled engineering tool support for analyzing software have created 
challenges to be dealt with [34]. 
Thus, there is a need for the development of an integrated model, which incorporates best 
practice and regulatory compliance, which is domain specific to medical device software 
development.  To address this Medi SPICE [35], comprising of a process reference model 
and a process assessment model for software development in the medical devices domain 
is being developed by the authors.  Medi SPICE brings together the best practice from 
15504-5 and the regulatory requirements of the medical device standards which include ISO 
13485, ISO/IEC 62304, and ISO 14971and FDA GPSV. Medi SPICE will also incorporate 
and address the findings from this research. The authors believe that with the publication of 
Medi SPICE more specific guidance will be available for process design, assessment, and 
improvement in the medical device software industry [35].  
 
6. Conclusions  
The areas we have identified for improvement will provide guidance for the definition of the 
V&V processes in Medi SPICE.  Further to the definition of a set of processes and the 
associated practices related to V&V, the processes should be piloted in organizations within 
the medical device software development industry. Based on the results obtained and the 
feedback from the medical device software development industry, the processes will be 
evaluated and continuously improved.    
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